These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35766218)

  • 1. Intravenous treatment adherence of patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemic: experience of a single center.
    Konak HE; Armağan B; Güven SC; Atalar E; Karakaş Ö; Esmer S; Eksin MA; Polat B; Apaydin H; Gök K; Doğan İ; Erden A; Maraş Y; Küçükşahin O; Omma A; Erten Ş
    Rom J Intern Med; 2022 Sep; 60(3):173-181. PubMed ID: 35766218
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
    Andreica I; Jast R; Rezniczek GA; Kiefer D; Buehring B; Kiltz U; Baraliakos X; Braun J
    Clin Exp Rheumatol; 2022 Nov; 40(11):2044-2051. PubMed ID: 35084321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.
    Melong Pianta Taleng CM; Lauper K; Gilbert B; Cunningham T; Guemara R; Brulhart L; Dan D; Courvoisier D; Finckh A
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.
    Kashiwado Y; Kimoto Y; Sawabe T; Irino K; Nakano S; Hiura J; Wang Q; Kawano S; Ayano M; Mitoma H; Ono N; Arinobu Y; Niiro H; Hotta T; Kang D; Akashi K; Ohshima S; Takeuchi T; Horiuchi T
    Mod Rheumatol; 2023 Mar; 33(2):367-372. PubMed ID: 35411376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD.
    Roman I; Andreica I; Baraliakos X; Redeker I; Kiltz U; Braun J
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221093760. PubMed ID: 35707223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions.
    Krasselt M; Wagner U; Nguyen P; Pietsch C; Boldt A; Baerwald C; Pierer M; Seifert O
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI180-SI188. PubMed ID: 35143648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?].
    Braunisch MC; Bachmann Q; Hammitzsch A; Lorenz G; Geisler F; Schmaderer C; Heemann U; Moog P
    Z Rheumatol; 2021 Jun; 80(5):408-417. PubMed ID: 33258019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
    Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
    J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases.
    Boyadzhieva VV; Stoilov NR; Stoilov RM
    Rheumatol Int; 2020 Nov; 40(11):1753-1762. PubMed ID: 32930863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases.
    Gros C; Mariaggi AA; Meritet JF; André E; Boisson M; Combier A; Descamps E; Frantz C; Wanono S; Morel J; Avouac J; Rozenberg F; Miceli-Richard C; Fogel O
    Joint Bone Spine; 2022 May; 89(3):105312. PubMed ID: 34883243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
    Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
    Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in rheumatic disease patients on immunosuppressive agents.
    Sharmeen S; Elghawy A; Zarlasht F; Yao Q
    Semin Arthritis Rheum; 2020 Aug; 50(4):680-686. PubMed ID: 32512263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 outcomes in persons with multiple sclerosis treated with rituximab.
    Iyer RB; S R; M JN; R J
    Mult Scler Relat Disord; 2022 Jan; 57():103371. PubMed ID: 35158435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases.
    Bachiller-Corral J; Boteanu A; Garcia-Villanueva MJ; de la Puente C; Revenga M; Diaz-Miguel MC; Rodriguez-Garcia A; Morell-Hita JL; Valero M; Larena C; Blazquez-Cañamero M; Guillen-Astete CA; Garrote S; Sobrino C; Medina-Quiñones C; Vazquez-Diaz M
    J Rheumatol; 2021 Jul; 48(7):1098-1102. PubMed ID: 33722949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.